Queensland Health
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Pembrolizumab in Cutaneous Squamous Cell Carcinoma (NCT05025813) | Queensland Health | 2022-06-28 |
Track Queensland Health automatically
Every clearance here is in the API, with alerts when new ones post.